ORGANIZATION
USAID
YEAR PUBLISHED
2006
DESCRIPTION
This report, prepared under the aegis of the Private Sector Partnerships-One (PSP-One) project, examines Indian manufacturers of generic versions of hormonal contraceptives (oral contraceptive pills, emergency contraception, and injectable contraceptives) and intrauterine devices. The principal question this report addresses is whether Indian manufacturers of contraceptive products are in a position to serve as a main source of contraceptives for the domestic and regional markets in a commercially viable manner. Brands multinational corporations produce and market dominate the high-end market in India, while free and subsidized products the government and social-marketing organizations underwrite occupy the low-end. This assessment finds that Indian manufacturers have the capacity to supply middleand low-end markets with affordable, quality contraceptives. These manufacturers, however, face two significant problems: a lack of marketing and distribution capability, and the difficulty and risk involved in approaching new markets, domestically and internationally.